RAMS participates in AussieDex Trial
Retinal and Macular Specialists are participating in the Aussiedex trial. This trial is a multicentre, open-label, prospective, Phase 4 study assessing the efficacy and side effects off intravitreal Ozurdex for the treatment of diabetic macular oedema in pseudophakic patients. Ozurdex is a long-lasting dexamethasone implant, that in this study is given up to every 4 months. Patients can be treatment naive, or have failed treatment with anti-VEGF therapy. Exclusion criteria includes advanced glaucoma and aphakia. If you would like to consider enrolling a patient in the AussieDex trial, please contact one of our clinics.